Egedesø PJ, Hansen CW, Jensen PS (2020) Preventing the white death: tuberculosis dispensaries. Econ J 130(629):1288–1316. https://doi.org/10.1093/ej/ueaa014
Cliff JM, Kaufmann SH, McShane H, van Helden P, O’Garra A (2015) The human immune response to tuberculosis and its treatment: a view from the blood. Immunol Rev 264(1):88–102. https://doi.org/10.1111/imr.12269
Article CAS PubMed PubMed Central Google Scholar
Purmohamad A, Azimi T, Nasiri MJ, Goudarzi M, Zangiabadian M, Sedighian H et al (2020) HIV-tuberculous meningitis co-infection: a systematic review and meta-analysis. Curr Pharm Biotechnol. https://doi.org/10.2174/1389201021666200730143906
Mahajan NS, Dhawale S (2015) Linked pyridinyl-thiadiazoles: design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis. Eur J Med Chem 102:243–248
Article CAS PubMed Google Scholar
Fatima S, Kumari A, Das G, Dwivedi VP (2020) Tuberculosis vaccine: a journey from BCG to present. Life Sci 252:117594. https://doi.org/10.1016/j.lfs.2020.117594
Article CAS PubMed Google Scholar
Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PEM et al (2013) Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 58(4):470–480. https://doi.org/10.1093/cid/cit790
Khoshnood S, Heidary M, Haeili M, Drancourt M, Darban-Sarokhalil D, Nasiri MJ et al (2018) Novel vaccine candidates against Mycobacterium tuberculosis. Int J Biol Macromol 120(Pt A):180–188. https://doi.org/10.1016/j.ijbiomac.2018.08.037
Article CAS PubMed Google Scholar
Kaufmann SH, Weiner J, von Reyn CF (2017) Novel approaches to tuberculosis vaccine development. Int J Infect Dis 56:263–267. https://doi.org/10.1016/j.ijid.2016.10.018
Aagaard C, Hoang T, Dietrich J, Cardona P-J, Izzo A, Dolganov G et al (2011) A multi-stage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 17(2):189
Article CAS PubMed Google Scholar
Farsiani H, Mosavat A, Soleimanpour S, Sadeghian H, Akbari Eydgahi MR, Ghazvini K et al (2016) Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex. Mol Biosyst 12(7):2189–2201. https://doi.org/10.1039/c6mb00174b
Article CAS PubMed Google Scholar
Kebriaei A, Derakhshan M, Meshkat Z, Eidgahi MR, Rezaee SA, Farsiani H et al (2016) Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis. Mol Biol Rep 43(9):911–922. https://doi.org/10.1007/s11033-016-4024-9
Article CAS PubMed Google Scholar
Mosavat A, Soleimanpour S, Farsiani H, Sadeghian H, Ghazvini K, Sankian M et al (2016) Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. Infect Genet Evol 39:163–172
Article CAS PubMed Google Scholar
Babaki MKZ, Taghiabadi M, Soleimanpour S, Moghadam MS, Mosavat A, Amini AA et al (2019) Mycobacterium tuberculosis Ag85b: hfcγ1 recombinant fusion protein as a selective receptor-dependent delivery system for antigen presentation. Microb Pathog 129:68–73
Abebe F (2019) Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: a review of current understanding. Int Rev Immunol 38(4):172–179. https://doi.org/10.1080/08830185.2019.1632842
Article CAS PubMed Google Scholar
Amelio P, Portevin D, Reither K, Mhimbira F, Mpina M, Tumbo A et al (2017) Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania. PLoS Negl Trop Dis 11(7):e0005817. https://doi.org/10.1371/journal.pntd.0005817
Article CAS PubMed PubMed Central Google Scholar
Cardona P, Cardona PJ (2019) Regulatory T cells in Mycobacterium tuberculosis infection. Front Immunol 10:2139. https://doi.org/10.3389/fimmu.2019.02139
Article CAS PubMed PubMed Central Google Scholar
Babaki MKZ, Soleimanpour S, Rezaee SA (2017) Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design. Microb Pathog 112:20–29
Wiker HG, Harboe M (1992) The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 56(4):648–661
Article CAS PubMed PubMed Central Google Scholar
Forrellad MA, Klepp LI, Gioffré A, Sabio y Garcia J, Morbidoni HR, Santangelo MDLP, Cataldi AA, Bigi F (2013) Virulence factors of the Mycobacterium tuberculosis complex. Virulence 4(1):3–66. https://doi.org/10.4161/viru.22329
Article PubMed PubMed Central Google Scholar
Kuo CJ, Bell H, Hsieh CL, Ptak CP, Chang YF (2012) Novel mycobacteria antigen 85 complex binding motif on fibronectin. J Biol Chem 287(3):1892–1902. https://doi.org/10.1074/jbc.M111.298687
Article CAS PubMed Google Scholar
Ramachandra L, Smialek JL, Shank SS, Convery M, Boom WH, Harding CV (2005) Phagosomal processing of Mycobacterium tuberculosis antigen 85B is modulated independently of mycobacterial viability and phagosome maturation. Infect Immun 73(2):1097–1105. https://doi.org/10.1128/iai.73.2.1097-1105.2005
Article CAS PubMed PubMed Central Google Scholar
Huygen K (2014) The immunodominant T-cell epitopes of the mycolyl-transferases of the antigen 85 complex of M. tuberculosis. Front Immunol 5:321. https://doi.org/10.3389/fimmu.2014.00321
Article CAS PubMed PubMed Central Google Scholar
Dey B, Jain R, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK (2011) A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis. PLoS One 6(8):e23360. https://doi.org/10.1371/journal.pone.0023360
Article CAS PubMed PubMed Central Google Scholar
Taylor JL, Wieczorek A, Keyser AR, Grover A, Flinkstrom R, Karls RK et al (2012) HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule. Immunol Cell Biol 90(10):945–954
Article CAS PubMed PubMed Central Google Scholar
Levin D, Golding B, Strome SE, Sauna ZE (2015) Fc fusion as a platform technology: potential for modulating immunogenicity. Trends Biotechnol 33(1):27–34
Article CAS PubMed Google Scholar
Mohammadzadeh R, Karbalaei M, Soleimanpour S, Mosavat A, Rezaee SA, Ghazvini K et al (2021) Practical methods for expression of recombinant protein in the Pichia pastoris system. Curr Protoc 1(6):1155. https://doi.org/10.1002/cpz1.155
Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25(24):4876–4882. https://doi.org/10.1093/nar/25.24.4876
Article CAS PubMed PubMed Central Google Scholar
Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J et al (2009) Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins 77(9):114–122
Article CAS PubMed PubMed Central Google Scholar
Krieger E, Koraimann G, Vriend G (2002) Increasing the precision of comparative models with YASARA NOVA—a self-parameterising force field. Proteins 47(3):393–402
Article CAS PubMed Google Scholar
Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2(9):1511–1519. https://doi.org/10.1002/pro.5560020916
Article CAS PubMed PubMed Central Google Scholar
Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstrøm T, Agger EM, Andersen P et al (2010) Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J Control Release 145(2):102–108. https://doi.org/10.1016/j.jconrel.2010.03.027
Article CAS PubMed Google Scholar
Tarokhian H, Rahimi H, Mosavat A, Shirdel A, Rafatpanah H, Akbarin MM et al (2018) HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions. BMC Cancer 18(1):1287. https://doi.org/10.1186/s12885-018-5209-5
Article CAS PubMed PubMed Central Google Scholar
Mao F, Leung W-Y, Xin X (2007) Characterization of EvaGreen and the implication of its physicochemical properties for qPCR applications. BMC Biotechnol 7(1):76. https://doi.org/10.1186/1472-6750-7-76
留言 (0)